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PURPOSE 
The purpose of this work was to study and select 
. 
from thirty different drugs those with the ability to par-
tially or completely suppress the infectivity of Newcastle 
disease virus and vesicular stomatitis virus in tissue cul-
tures. Drug(s) showing significant activity in tissue cul-
tures should be tried out in fertilized eggs or animals. Fin-
ally, the drug(s) with therapeutic activity in vitro and in 
vivo should be further studied using biological, biochemical 
and histochemical techniques, in order if possible, to eluci-
date the mechanism(s} of it~(their) inhibitory action. 
The general purpose of this work was to contribute 
to the field of Chemotherapy of viral diseases, which due to 
very intricate virus-host cell relationships, has not been 
achieved on a practical and clinical level. 
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CHAPTER I 
INTRODUCTION 
In 1909 Ehrlich proposed the word chemotherapy to 
denote the concept of therapy of bacterial diseases by means 
of drugs selectively toxic for the parasites. 
On this basis chemotherapy is defined as the treat-
ment of infectious diseases in vivo by chemical agen~s which 
are specifically toxic for the etiological agents without ser 
ious toxic or damaging effects for the host. 
The discovery by Domagk (1935) that prontosil, an 
azo dye, significantly inhibited streptococcal infections in 
mice with no toxic effect for mice, and subsequent findings 
on the mechanism of its action by Woods (1940), prompted 
Fildes (1940) to propose a rational approach to research in 
chemotherapy of infectious diseases. This approach was log-
ical, and synthetic compounds such as sulfones, aminohydroxy-
benzoic acid and the derivatives of pyridine carboxylic acid 
were found which are used successfully against infections 
caused by acid fast bacilli (Burrows, 1955). 
The discovery of penicillin and streptomycin and 
later of broad spectrum antibiotics such as tetracyclines and 
chloramphenicol greatly contributed to the array of thera-
peutic agents available for treatment of bacterial diseases 
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and also diseases caused by rickettsiae and chlamydozoa. 
The studies of the mechanisms of the action of 
these agents pointed to selective inhibition of various meta-
bolic activities which had a lethal or inhibiting effect on 
the pathogen. The inability of gram positive bacteria to 
synthesize their cell wall in the presence of penicillin' 
(Lederberg, 1957), or the inhibition by streptomycin of the 
Krebs cycle (Oginskyand Umbreit, 1954), and the interference 
with transamination reactions of Mycobacterjum tuberculosis 
by isonicotinic acid hydrazide are only a few examples of 
inhibitory mechanisms. 
The results of these studies demonstrate that chemo 
therapy is possible if the parasite exhibits metabolic ac-
tivity which may be inhibited by a drug. 
Chemotherapy today is relatively successful in com-
bating many diseases of protozoan, bacterial, rickettsial and 
chlamydozoan etiology, whether the parasite is found intra-
cellularly or extracellularly. The only group of obligate 
intracellular parasites against which chemotherapy has been 
ineffective is the group of "true" viruses. It becomes clear 
that the intracellular mode of life of diversified organisms 
and entities, when examined from the viewpoint of chemother-
apy, is graded, and therefore should depend on different fac-
tors. The reproduction of viruses and the metabolism of the 
host cells is such an intimately shared mechanism that selec-
tive inhibition of virus is difficult. 
-CHAPTER II 
HISTORY 
The word virus comes from the Latin noun meaning 
venom or similar toxic fluid. It was used from ancient times 
until very recently, denoting all sorts of noxious and poison-
ous agents,. (Fraenkel-Conrat, 1962). Even today the word 
"virus" is an intractable one. It (virus) refers to a charac-
teristic complex of recognizable qualities associated with a 
natural or experimental disease rather than to the individual 
unit or microorganism which one tends to speak of as a virus 
particle (Burnet, 1960). 
Viruses probably would never have been discovered if 
they did not .nave the property of causing disease. The idea 
of submicroscopic nonbacterial pathogens was very slow in 
finding its experimental basis (Luria, 1953). Progress was 
slow. A century before Iwanovski reported the transmission of 
tobacco mosaic disease by means of sap filtered through bac-
teriological filters~ Jenner was successful in vaccinating the 
children of England with "Variolae Vaccinae." Transmission of 
rabies from a rabid to a normal dog by means of filtered sali-
va was reported by Zinke in 1804, some seventy~five years be-
fore Pasteur's preparation of antirabies vaccine. None of 
them knew the true nature of these agents. Pasteur might have 
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perceived the true biological character of the rabies virus, 
but it remained for bacteriologist Beijerinck (1899), after 
rediscovering the virus of tobacco mosaic disease, to recog-
nize that he was dealing with a new type of biological agent, 
and promptly called it, on the basis of its filterability 
through bacteriological filters, "contagium vivum fluidum." 
Following Beijerinck's work, a number of people dis-
covered a variety of filterable infectious agents. Borrel 
(1904) reported the discovery of the agent of fowl plague; 
Paschen (1906) rediscovered the elementary particles of vac-
cinia, which were studied and called by Buist (1887) micro-
cocci of vaccinia; von Prowazek (1907) describes trachoma and 
Landsteiner and Popper (1909) poliomyelitis virus. 
In the three decades following the work of Beijer~~ 
important progress in the study of the cellular pathology of 
several viral diseases had been achieved. (Negri, 1903; 
Councilman, 1904; da Rocha Lima, 1912; Denton, 1925; Lillie, 
1930), Despite this, virology as an integrated part within the 
broader scope of microbiology did not exist. 
With the discovery of bacterial viruses by Twort 
-(1915) and d'Herelle (1917), and their subsequent study (Bur-
net and McKie, 1929; Ellis and Delbruck, 1939; Hershey, 1946), 
it became clearer that for successful study of the properties 
of animal viruses a simple host system should be used. 
The inability to measure quantitatively viral 
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infectivity in simple systems on one hand and the need for 
such studies on the other, disturbed early virologists, as onE 
can conclude from Enders (1959): 
It is not surprising that attempts to propagate 
animal viruses and rickettsiae in isolated systems 
of cells followed the development by Harrison (1907) of a ~imple method of tissue culture, for it was 
early apparent to most observers that these agents, unlike bacteria, fail to multiply in lifeless media. Although the method was applied in the past effect-ively to the investigation of several fundamental problems relating to animal viruses, during a long period it did not appear to offer advantages for their cultivation and study provided by the suscept-ible animal, since it was considered that viral in-crease in cell systems could be demonstrated re-liably only by inoculation of appropriate animals with constituents of the culture. Recently, how-ever, tissue culture has assumed the status of a major technic in the virus laboratory. 
There are actually three good reasons for this development: 
a) use of antibiotics in the medium supporting the 
growth of cells which are the hosts for a variety 
of viruses, made it possible to prepare tissue 
cultures on a large scale and permitted direct i50-
lation of viruses from contaminated materials; 
b) use of Rous and Jones (1916) technic of trypsiniza-
tion of tissues in the preparation of cellular sus-
pensions; 
c) observation and recognition that many viruses, 
when present in tissue cultures and multiplying 
in the cells are responsible for degenerative 
changes, which are easily detected and known under 
general terms of cytopathic effects (Huang, 1942). 
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With the advancement of modern tissue culture tech-
niques many concepts about viruses were reaffirmed and some 
had to be changed. 
Ihe nature of viruses. Some physical. chemical and biological 
j2TopeTties. 
Reports on infectious agents passing filters retaining even 
the smallest bacteria indicated to early workers their diminu-
tive sizes. But it was actually Elford (1931) who published 
the first reports on the estimation of the sizes of viruses, 
using graded collodion membranes. Later, the use of the elec-
tron microscope and the ultracentrifuge improved these meas-
urements. The application of the electron microscope with 
newer techniques have given us more details of viral morpholo-
gy (Howatson and Whitmore, 1962; Brenner and Horne, 1959). 
'. 
The first work on the chemical properties of viruses 
was done by Vinson and Petre (1929, 1931) which led to the 
crystallization of tobacco mosaic virus by Stanley (1935) and, 
among others, poliomyelitis virus by Schaffer and Schwerdt 
(1955). Chemical analyses of "purified" virus preparations 
report findings of nucleic acids, protein, and in some in-
stances, lipids and polysacharides (Taylor et al., 1942;Smadel 
and Hoagland, 1942; Ada and Perry, 1954). All viruses contain 
either RNA or DNA and protein and in some cases (Myxoviruses) 
exhibit enzymatic properties. Lipid and polysacharide 
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materials mayor may not be considered integral parts of viru 
Some people believe that the lipids found in some viruses are 
acquired by the virus as it emerges through the cytoplasmic 
membrane. Treating viruses to remove lipids renders them non-
infective (Theiler, 1957; Franklin, 1962). Viruses when in-
troduced into their hosts, stimulate the immune mechanisms to 
produce antibodies. This is due to the antigenic nature of 
their proteins and nucleoproteins. Since these antibodies are 
in many instances protective, inactivated or attenuated viral 
preparations are used as vaccines (Schaffer and Zillig, 1954; 
Sabin, 1957; Salk, 1955). 
Viruses exhibit the properties of genetically indi-
vidual entities. They are subject to genetic mutations. For 
example, the recovery of different, but serologically stable 
strains of Influenza A virus since the pandemic of 1918 (Fran-
cis, et al., 1953; Hennesy, 1955). Other studies confirm the 
ability of viruses to mutate and recombine, giving stable, new 
types, which differ from the parent types, either in host 
range, virulence or sensitivity to various agents (Berry and 
Dedrick, 1936; Luria, 1956). 
Rous (1911) showed that viruses are responsible for 
some tumor formation in chickens. In recent years, it was 
shown by Gross (1956) that mouse leukemia could be transferred 
from one animal to another by means of a filtrate of leukemic 
tissue. Shope (1933) isolated a virus (Shope papilloma) from 
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naturally occurring papillomas of wild rabbits. This papil-
loma is a nonmalignant growth. If filtrates of such tumors 
are inoculated into the skin of either wild or domestic rab-
bits, tumors are induced in the animals. Virus could be re-
isolated from wild rabbits but not from the tumors in domestic 
animals. Such papillomas are usually benign growths, but af-
ter long periods of time (Kidd and Rous, 1940) they may be-
come malignant. 
During 1950 it was demonstrated that the nucleic 
acids of viruses were the carriers of the biological informa-
tion necessary for their replication. Hershey and Chase (1952) 
in what are considered classical experiments, demonstrated 
this with bacterial viruses using radioisotope techniques. 
Direct evidence for this phenomenon comes from work of Alexan-
der et al •• (19~8) in which the infectivity of poliomyelitis 
virus RNA was proven on HeLa cells. Since in nature virus 
nucleic acids are contained in a protective protein coat, a 
successful contact between the viral protein coat and the sur-
face of a susceptible cell is a prerequisite for penetration 
of the cellular membrane by viral nucleic acid. In all sys-
tems so far studied specific electrolyte requirements exist, 
(Kozloff et al •• 1957) for the attachment and adsorption of a 
~ral particle to the surface of a cell. The discovery of ag-
glutination of chicken erythrcytes by influenza viruses by 
Hirst (1941) and the study of its mechanism by S. Gottschalk 
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(1956) pointed to the phenomenon of adsorption of viral parti-
cles to the receptor groups on the surface of susceptible 
cells, as the first ~tep in subsequent events. 
Various histochemical procedures {Coons, 1958. 1959; 
Armstrong, 1956; Anderson, et al., 1959} confirmed the concept 
of an eclipse period as a part of the latent period of viral 
intracellular development. This concept was proposed by Ellis 
and Delbruck (1939), as a result of their "One step growth ex-
periments," with bacterial viruses and later applied to animal 
viruses by Dulbecco (1952) and Dulbecco and Vogt (1954). 
During this period the first comprehensive defini-
tions of "virus" were proposed. Luria (1956) defined it as 
follows: "Viruses are submicroscopic entitie~, capable of be-
lng introduced into specific living cells, and of reproducing 
inside such cells only." Due to quick development of new con-
cepts based on new findings and hypotheses, Luria (1958) de-
fines the "virus" somewhat differently: 
Viruses could be considered as genetically specific 
cell constituents, containing coded DNA or RNA which 
can, as one of their genetic functions, determine 
their own incorporation into specific vehicles for 
transmission to other cells. 
Experim~Dtal chemotherapy of viral diseases 
The first attempts at the chemotherapy of viral diseases ap-
peared in the literature in late 1940. There are a number of 
good reviews on the progress to date in this area. For 
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example, Matthews and Smith (1955), Hurst and Hull (1956), 
Horsfall and Tamm (1957) and Staehelin (1959). 
A. Amino acids and analogs 
Thompson (1947) reported that dl-methoxinine, an 
analog of methionine, inhibits the growth of vaccinia virus in 
Maitland type (minced) tissue cultures of chicken embryos. 
Rafelson, et al., (1950) found that beta-2-thienylalanine in-
hibited multiplication of Theiler's GO VIr virus in minced 
mouse brains, with no apparent effect on the uptake by this 
tissue of p32 into its lipid and protein bound fractions •. It 
was also reported in the same paper, that lysine, and to a 
somewhat lesser extent, tryptophan and histidine inhibited the 
growth of GO VII virus, and that the inhibition by lysine was 
reversed by methionine. 
Ackermann (1951) showed that methoxinine inhibited 
the growth of PR 8 strain of Influenza A virus in intact tis-
sue cultures of chicken chorioallantoic· membrane (CAM). The 
inhibitory effect of methoxinine was reversed by L-methionine 
but not O-methionine, cysteine, creatine, betaine or choline. 
Methoxinine did not affect the oxygen uptake by CAM. Acker-
mann and Maassab (1954) found that methoxinine inhibits the 
growth of Influenza virus if it was added 2-3 hours after 
viral adsorption on CAM. On the other hand, alpha-amino-p-
methoxyphenylmethanesulfonic acid was inhibitory only at the 
initial stage of infection causing delayed viral release from 
~'-------------------------------------------------, 
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the CAM cells. 
Inhibition of the Lansing strain of poliomyelitis 
virus by DL-ethionine in minced human embryonic brain was re-
ported by Brown and Ackermann (1951). In this case methionine 
competitively inhibited the action of Dl-ethionine, which was 
not virucidal in vitro, and which did not irreversibly affect 
the tissue. Basic amino acids such as lysine, arginine and 
ornithine, at concentrations from 1-10 mg per ml of growth 
medium, retarded the growth of Influenza A and B viruses as 
well as Mumps virus in minced tissue cultures of chicken CAM, 
according to Eaton et al., (1951). Ackermann and Maassab 
(1955) showed that inhibitory properties of 5-fluorophenylala-
nine (FPA) on the Influenza virus when grown in CAlVi differ 
from those of methoxinine. Release of FPA inhibition results 
in immediate continuation of viral production, whereas in the 
case of methoxinine at least a two hour lag ensues before any 
detectable increase in viral infectivity could be measured. 
Kundin et al., (1959) reported that several amino 
acids and their derivatives inhibit the growth of Influenza A 
and B viruses in chicken embryo lung tissue cultures. Partic-
ularly good inhibition was achieved with norleucine, beta-
phenylserine, allylglycine and ethylcysteine. 
It has been shown that 5-fluorophenylalanine inhibit 
the growth of foot and mouth virus (Brown et al., 1961). poli-
omyelitis virus (Levintow and Darnell, 1961), fowl plague 
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(Zimmermann and Schaffer, 1960) in different host systems and 
under a variety of conditions. 
B. Purines and pyrimidine analogs 
Purine and pyrimidine analogs can act in two ways. 
They either inhibit metabo~ic steps leading to the synthesis 
of nucleic acids. or by virtue of their incorporation into 
virus nucleic acids they can decrease viral infectivity or 
produce nonfunctional nucleic acids. 
It was shown by Matthews (1953) that 8-azaguanine is 
the most active inhibitor of tobacco mosaic virus in a series 
of purine and pyrimidine analogs. The activity was probably 
due to its incorporation into RNA of virus (Matthews and Smith 
1955), because the only other active analogs. 8-azaadenine and 
4 (5)-Amino-1H-l, 2, 3-Triazolo-5(4)-carboxamide were also in-
corporated. Haas and Stewart (1956) reported the synergistic 
inhibitory effect of8-azaguanine and amethopterin on lympho-
cytic choriomeningitis virus in mice. 
Thiouracil was reported to inhibit tobacco mosaic 
virus in tobacco plants (Commoner and Mercer, 1951). The ef-
fect of thiouracil could be reversed by uracil (Commoner and 
Mercer, 1952). This could be done only during early stages 
of infection as reported by Jeener {1957}. 
Knox et al •• (1957) showed that 2-thiouracil, 2-thio 
4-phenyl-6-oxy-pyrimidine. 5-methyl-2-thiouracil and 4,6-
diamino-5-nitro-2-thio-pyrimidine completely suppress the 
'. i 
, 
... 
. 
...... 
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growth of poliomyelitis virus in cultures of monkey testicles 
for a period up to 12 days. In monkey kidney cultures, growth 
waS delayed for 24 hours and even then it was significantly 
lower than in controls. Higher concentrations of the drugs 
were needed to inhibit type 1 than types 2 or 3 virus. This 
inhibition was reversed by addition of normal pyrimidines. 
Amos and Vollmayer (1955) reported the inhibitory effects of 
thiouracil on Influenza A virus in CAM and deembryonated 
chicken eggs. Infectivity and hemagglutinating activity of 
the virus was suppressed. Uracil acted competitively; since 
it could overcome the effect of thiouracil. Minton et al., 
(1953) showed that phenoxy thiouracil protected mice against 
intranasal or intracerebral infections by vaccinia. The 
compound could be given intraperitoneally or with the diet, 
but it was not effective if given 2 days after infection. 
Flu·orouracil (Kaplan and Ben-Porat, 1961) inhibi ts the forma-
tion of infective pseudorabies virus in rabbit kidney cells. 
This inhibition was overcome by thymidine. The same drug pro-
longs the life of mice infected intracerebrally with lymph-
ocytic choriomeningitis virus (Levy and Haas, 1958). Rich 
~t al., (1962) found that 5-f1uorodeoxyuridine (FUDR) does not 
inhibit the synthesis of Rous sarcoma virus in chick embryo 
fibroblasts. FUDR, on the other hand, inhibits the multipli-
cation of DNA containing vaccinia virus (Salzman et al.,1963). 
Tenfold to hundredfold higher concentrations of FUDR had no 
~: -
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effect on the rate of formation or final yield of RNA contain-
ing poliomyelitis virus, and Salzman suggests that FUDR could 
be used as a means of distinguishing between RNA and DNA con-
taining viruses. 
c. Benzimidazole and derivatives 
Work ~n benzimidazole compounds provides one of the 
more interesting recent developments in animal virus chemo-
therapy. This compound has some inhibitory effect on a number 
of viruses'" (Matthews and Smith, 1955). Extensive screening 
of benzimidazole derivatives and studies of their action on a 
number of viruses was started by Tamm in 1953 and continued 
until this date. Tamm (1956) showed that alkylated and halo-
genated benzimidazoles are much more inhibitory for influenza 
virus than benzimidazole, a component of vitamin B12• In 
another paper; Tamm (1956a) showed that beta-D-ribofuranosyl 
derivatives of benzimidazole are active at lower concentration 
and also that they were much more selective in their activity, 
since the ratio between toxic and inhibitory concentrations 
was two times higher in the case of 5, 6-dichloro-beta-D-
ribofuranosyJ:.benzimidazole (DRB) and 6 times as high with 4, 
5,6-trichloro-beta-D-ribofuranosyl-benzimidazole (TRE) when 
compared with free benzimidazole. This action was specific 
for beta ribofuranoside, the natural form in which nucleotides 
are .present in RNA. Influenza virus is an RNA containing 
Virus. Vaccinia virus, a DNA containing virus, is not 
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inhibited by these benzimidazole derivatives, which is sur-
prising (ramm and Nemes, 1957). But poliomyelitis virus was 
inhibited by an D-arabinosyl derivative, and therefore the 
inhibition of RNA containing viruses in this case is not too 
clear. This work was done mostly in tissue cultures and eggs, 
but there was also some activity in animals. Recently Tamm 
~ al., (1961) and Eggers and Tamm (1961) showed that 2(-alpha 
Hydroxybenzyl)-benzimidazole (HBB) is perhaps the most selec-
tive viral inhibitor among the variety of benzimidazole de-
rivatives which have been so far studied. Structurally HBB 
is not an analog of any known metabolite, but it inhibits re-
versibly a late step in replication of many enteroviruses by 
an unknown mechanism. Kissman et ale, (1957) report on the 
other hand that DRB was inactive against PR 8 strain of In-
fluenza A virus .. in mice. 
D.· Miscellaneous compounds 
Caprochlorene (liu et al., 1957) reduced infectiv-
ity and hemagglutinin titers of PR 8 influenza virus in de-
embryonated eggs. Twenty hours after infection with virus the 
compound was active, although not as markedly as in earlier 
treatment. The compound protected mice almost completely (19 
out of 20) against the virus. Hamre et alp, (1951) reported 
the ability of thiosemicarbazones to inhibit multiplication 
of vaccinia virus in mice. Mepacrine, an antimalarial drug, 
(Greenhalgh et al.,1956) protected mice against large doses of 
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°a number of arbor viruses when the drug was given orally soon 
after infection. Xerosine, an antibiotic obtained from an 
Achromobacter species, showed a number of interesting proper-
ties (Groupe, et al., 1952). If mice were infected intra-
nasally with 10,000 LD50 of influenza A virus, subcutaneous 
xerosine was effective even 48 hours after infection of the 
animals. Orally, xerosine was not effective, and highly 
toxic when given intraperitoneally. It seems that tissue re-
actions have an important role in treatment with xerosine, 
rather than its ability to; suppress viral multiplication 
(Groupe et al., 1954). 
Chrowther and Melnick (1961) found that guanidine. Hel 
inhibited production of poliomyelitis virus in monkey kid-
ney tissue cultures. Rightsel et a 1., (1961) reported 
the inhibitioQ of variousenteroviruses by this compound. 
Treatment of monkeys infected with poliomyelitis virus was 
unsuccessful. 
Mitomycin C, an antibiotic product of Streptomyces 
caespitQsus, according to Reich and Franklin (1961) does 
not inhibit the RNA containing Mengo virus at the doses which 
markedly suppressed DNA containing vaccinia virus. Shatkin 
tl al., (1961) studied the effect of mitomycin C on mam-
mallian cells, and reported that it causes dissolution of the 
nuclear apparatus in a manner similar to ionizing radiation. 
Reports by Ben-Porat et al., (1961) on the formation of in-
0'-
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complete pseudorabies virus in rabbit kidney cells in the 
presence of mitomycin, and only very slight inhibition (Gomato 
et al., 1962) of Reovirus type 3 in L cells, confirms its ac-
-
tion on DNA. 
Puromycin (Levintow et al., 1962) inhibits multipli-
cation and maturation of poliomyelitis virus in HeLa cells 
when the infected cells are treated early. Removal of puro-
mycin by washing of the infected cells brings about resumption 
of normal viral replication. Baltimore and Franklin (1962) 
and Franklin and Baltimore (1962) reported that puromycin in-
hibits the formation of Mengo virus RNA in L-fibroblast cells, 
probably through the mechanism of blocking the formation of 
new protein in the infected cells that might serve as virus 
specific RNA polymerases. 
A number of basic dyes were studied as possible vir 
therapeutics (Matthews and Smith, 1955). The findings result-
Ing were not too promising. More recently the inhibitory ac-
tion of proflavine on fowl plague virus was reported by 
Franklin (1958). 
E. Interferon 
Isaacs and Lindemann (1957) rep6rted discovery of a 
proteinaceous substance which they called interferon, and 
which is the product of virus-infected cells. According to a 
number of investigators, interferons from various sources have 
a wide spectrum of antiviral action and exhibit no particular 
.... 
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specificity for the viruses responsible for their formation. 
The difficulty in using interferon as a therapeutic agent is 
the inability to prepare and purify it in the quantities which 
could be effective in man and animals. 
CHAPTER III 
MATERIAL AND METHODS 
Viruses used·in this work were obtained from 
Dr. F. Deinhardt, St. Luke-Presbyterian Hospital, Chicago, 
Illinois, and Dr. D. Hamre, University of Chicago, Chicago, 
Illinois. 
The Roakin strain of Newcastle disease virus (NOV) 
was passed twice in eggs, before stocks were made. Prior to 
that, virus was passed 7 times at Rutgers University, 17 times 
at the University of Wisconsin and several times at the Univ-
ersity of Chicago. The LD50 titer of this strain for chicken 
embryo can reach 109 and it is uniformly lethal when inoc-
ulated intracer~brally. Hemolysin titers of 1:128 were ob-
served and hemagglutinin (HA) titers of 1:1280. 
The Indiana strain of vesicular stomatitis virus 
(VSV) was passed intracerebrally in mice several hundred times 
as well as numerous foot pad passages in mice, several epi-
thelial passages in cattle and horses and more than 20 pas-
sages in eggs. In our laboratory it was passed 3 times throug'h 
chicken eggs before preparations of viral stocks. 
Fertilized, white leghorn chicken eggs were obtained 
once a week from a nearby hatchery, and incubated at 37 0 C upon 
arrival. Ten day-old embryos served as source of primary 
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embryonic cells, otherwise the eggs were used for preparation 
of viral stocks and for embryo survival experiments. Several 
eggs were permitted to hatch, and chickens used as a source 
of blood for hemagglutination (HA) and hemagglutination-
inhibition (HI) tests. 
He La cells were obtained from Cappel Laboratories, 
Inc., and continuously cultivated in minimal essential medium 
(MEM) of Eagle (1959). 
Media and solutions 
Phosphate buffered saline (PBS) was prepared as des-
cribed by Dulbecco and Vogt (1954). It was used for washings 
of monolayers and as viral diluent. The composition of PBS 
is as follows: 
NaCl.·. o • • • • • • • • • • • .8.00 9 
KCl 
• • • 0 0 0 • • • • • • • 0.20 g 
Na 2HP04 • • • • • • • • • • • 1.15 g 
KH2 P04 • • • • • • • • • • • • 0.20 g 
CaC1 2 •• 
MgC1 2 .6 H20 
• • • • • • • • • • 0.10 g 
• • • • • • • •• 0.10 g 
• • • 0 • • o 0 1000 ml 
PBS was sterilized by autoclave. 
0.5% Lactalbumen-hydrolysate medium (LH) was pre-
pared according to Franklin et alo, (1958). It was used for 
growth of chicken embryo fibroblasts, and contained the 
following ingredients: 
90% Hanks' balanced salt solution (BSS) 
10% calf serum 
0.5% lactalbumen hydrolysate (enzymatic) 
0.1% yeast extract 
100 units of penicillin I ml 
50 ug of streptomycin I ml 
20 ug of fungizone I ml 
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Hanks' BSS was prepared as recommended by Hanks and 
Wallace (1949). Chicken fibroblasts were maintained for viral 
titrations in a maintenance medium of 0.01% lactalbumen hydro-
lysate, and 5% serum. Glutamine was added to contain 290 ug I 
mI. 
Trypsin solution was prepared as given by Marcus ~ 
" 
.al ... (1956) and consisted of the following: 
NaCl • • 0 0 • • • • • • • • • 20.00 9 
KCl 
• • 0 • • • • • • • • • • 1.00 9 
Glucose • • • 0 • 0 • • • • • 2.50 9 
NaHCO 
3 • • • • • • • • • • • 
1.45 9 
Trypsin (Difco lo250) 0 • 0 • 1.25 9 
Versene • • • • • 0 • • • • • 0.55 9 
Penicillin • • • • • • • • • 0 0 0 50 9 
Streptomycin 
• • • • • • • • • 0.25 9 
Deionized H20 to 250 ml 
This solution was sterilized'by Seitz filtration and stored at 
22 
When needed, it was thawed and diluted 1:10 with 
sterile deionized water. Trypsinization was done in special 
flasks designed for this purpose, on a magnetic stirrer. 
£reparation and harvests of viral stock ~ 
Viral stocks were prepared in fertilized, 10-day old 
chicken eggs by allantoic inoculation of 0.1 cc of 10-3 di-
lution of samples. Eggs incubated at 37 0 C were candled, the 
air space marked, and an area selected directly above the em-
bryo and showing no blood vessels. The area was swabbed with 
tincture of iodine, a small slit drilled through the shell 
carefully, avoiding the piercing of the shell membrane. Virus 
was inoculated using a 0.5 cc syringe with a 23-gauge, 1 inch 
needle, by inse~ting the needle through the slit, through the 
chlrioallantoic membrame (CAM) and away from the embryo toward 
the shell. Eggs were sealed and incubated at 370 C. The next 
day the eggs were candled again, and those with dead embryos 
discarded, assuming that deatffiwere due to nonspecific causes. 
After 48 hours the eggs were candled again, chilled in the re-
frigerator, and allantoic fluid harvested. Harvesting was 
done by sterilizing the entire shell with 70% alcohol, remov-
ing the entire shell above natural air space and collecting the 
fluid with a syringe, avoiding blood vessels. The allantoic 
fluids were pooled, distributed in I ml volumes in screw 
i 
-. 
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capped tubes, frozen immediately and stored at -20 oC. The 
presence of virus was determined either by hemagglutination or 
by cytopathic effect (ePE) in chick fibroblasts. Sterility 
tests for presence of bacteria were done in nutrient broth. 
Ereparation of monolayers of chicken embryo fibroblasts 
. , 
. 
~, )' 
" Monolayers were prepared according to Dulbecco(l952) . 
with small modifications. They were needed for screening of 
drug toxicities and for the titrations of viral infectivity 
in the presence or absence of drugs as well as for obtaining 
NDV hemagglutinin. The following steps were employed: 
10-12 day-old embryos were aseptically removed and placed in 
sterile petri plates. Beaks and eyes were removed, the em-
bryos cut up and these were washed with cold sterile PBS to 
eliminate as muc,h blood as possible. After washing, fragments' 
were placed in the barrel of a 20 cc syringe and expressed in-
to a trypsinizing flask. Ten ml of trypsin solution was added 
per embryo and the contents of the flask stirred for about 
20 minutes. After trypsinization the contents of the flask 
were filtered through sterile gauze, discarding undigested 
connective tissue with the gauze, and the cells in trypsin dis-
tributed among several centrifuge tubes. Cells were centri-
fuged at 600 G for 5 minutes, trypsin discarded and the pel-
lets washed with lactalbumin hydrolysate medium. After two 
washings, cells were counted in a hemocytometer and diluted in 
',' 
", 
i 
'i •. 
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LH to contain between 3-4 x 105 cells / ml and finally dis-
tributed among bottles or tubes and incubated at 37°C. It 
was found that each 0.1 cc of packed cells when diluted with 
20 ml of medium gave good results. with monolayers developing 
24 hours later. In spite of heterogenic cell origin in these 
primary cultures. most cells had a fibroblastic appearance. 
and th~efore they are referred to as primary chicken embryo 
fibroblasts. These were not carried continuously. but were 
prepared as needed. 
CyltivatiQn of HeLa cells 
HeLa cells were carried continuously. The growth 
medium actually contained 90% MEM (Eagle, 1959), 10% calf 
serum and usual amounts of antibiotics. The maintenance 
medium for HeLa cells differed only in the amount of serum. 
which was 4-5%. For staining purposes. cells were distributed 
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. in 1.5 ml amounts (2 x 10 cells / ml) among small Leighton 
tubes containing small cover slips. When needed. cover slips 
with attached cells were removed, cells stained by various 
procedures. mounted on glass slides. and examined. For RNA 
extractions, HeLa cells were infected with NDV, trypsinized 
and distributed in 3 x 106 cells aliquots among tubes and fed 
with maintenance medium. All the cells. whether normal or in-
fected, in the presence or absence of 5-fluorophenylalanine, 
were slowly rotated at 37 0 C, and after 24 hours in the incuoom~ 
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extracted for RNA. 
£Urine bound ribose determination 
RNA was· extracted from HeLa cells using the me"thod 
of Schmidt and Tanhauser (1945). Purine bound ribose deter-
minations on RNA extracted from HeLa cells were done as des-
cribed by Mejbaum (1939) and Ceriotti (1955) using orcinol 
method. Readings were done in Klett-Summerson colorimeter, 
using red filter (670mu). For this purpose a standard ribose 
curve was determined, using the same procedure. 
Drugs 
Drugs were secured from various sources. Informa-
tion as to solubilities was obtained from Merck's Index, 7th 
Ed.(1960). Drugs soluble in water were added directly to 
the medium, and sterilized by either filtration or autoclaving 
Drugs soluble in alcohol or chloroform were dissolved in them 
to the limit of their solubilities, and small aliquots added 
to the medium to get the desiied concentration, and sterilized 
by autoclave. Occasionally after the addition of the drugs 
to the media, adjustments to pH 7.3-7.5 were necessary, and 
this was done with sterile 0.3 N NaOH or 0.3N HCl. 
Assays of drug toxicities 
These assays were done as described by Rightsel ~ 
a!.,(1958). The method was modified in order to obtain the 
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best possible results in Leighton tubes. Briefly it consisted 
of exposing monolayers of chick fibroblasts to several con-
centrations of the particular drugs in maintenance LH and ob-
serving the action of the drug on the cells for a period of 
several days. Rounding of the cells, their detachment from 
the glass, and the unchanged pH were criteria of toxicity. 
Only the highest concentrations of drugs tolerated by cells 
were used in further experiments. 
Qualitative assays of viral infectivities in the presence of 
QruQs. 
Once the highest tolerated doses of the drugs were 
determined for the chicken fibroblasts, their potential anti-
viral activity was ascertained as follows: Monolayers of 24-
36 hours-old fibroblasts were infected with approximately 
1000 TCID50 of each virus. The cells were washed with PBS 
and the virus adsorbed for one hour at 37 0 C. The media con-
taining the drugs were then added and the tubes reincubated. 
Controls were also prepared. Each control tube contained the 
cells. Cell control contained only LH medium, drug control 
was prepared with LH medium containing the drug and the virus 
control contained LH medium and virus. The tubes were exam-
ined daily for 3-5 days. Cytopathic effect due to the pres-
ence of virus was scored as 0,1,2,3 and 4, depending on cell-
ular damage. Only those drugs which inhibited cytopathic 
effect to an extent of 3 (lowered CPE from 4 to 3 or lower as 
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compared'to virus control), and in at least three out of four 
tubes, were used in further experiments. 
~antitative assays of viral infectivities 
These assays were performed using the method of Reed 
and Muench (1938). Infected allantoic stocks were diluted 
with cold PBS. Aliquots of 0.1 ml of each dilution were in-
oculated into monolayers of cells, using for each dilution 
5-10 monolayer tubes. The monolayers were washed with PBS, 
virus adsorbed for one hour at 37 0 c with occasional tilting 
of the tubes in order to spread the virus evenly. After ad-
s~rption, medium was added and the tubes reincubated. Mono-
layers were examined daily, CPE scored and the viral titers 
obtained. 
Quantitative assays of viral infectivities in the presence of 
selec ted drugs 
These assays were done in exactly the same manner as 
the assays described above but on the virus formed in the 
chicken cells in the presence of drugso In order to obtain 
the virus, the cells in the tubes were frozen and thawed 
twice and vigorously pipetted, cell debris removed by centri-
fugation, and the fluid containing the virus titr~ted as above 
(Franklin, 1958). 
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liemagglutipation (HAl and hemagglutinatioQ-inhibition (HI) 
HA and HI tests (titrations) were done in cupped 
plastic trays, each cup having a volume of approximately 
2.6 mI. Chicken blood for this purpose was obtained by bleed 
ing chickens from the heart and collecting the blood in the 
following mixture: 
sodium citrate ••••••••••••••• 0.8 g 
sodium chloride •••••••••••••• O.4 g 
glucose ••••••••••••••••••••• 2.0 g 
sterile, dist. water 100 ml 
Cells were always kept in sterile refrigerated Alsever's so-
lution. When needed for HA or HI tests, a certain volume was 
removed, the cells sedimented by centrifugation and the super-
natant discarded. The cells were further washed in 2 changes 
of cold PBS and' finally prepared as 0.5% suspension in PBS. 
The actual HA tests were run as follows: to each 
cup in the plastic trays was added 0.5 ml of cold PBS. The 
infected fluids were diluted in PBS and to each 0.5 ml of di-
luted fluid 0.5 ml of 0.5% chicken red blood cells was added. 
covered with a plastic coverand refrigerated. Two hours later 
the HA titers were read as the highest dilution of fluid 
which completely agglutinated the cells. 
HI tests were performed in a similar way. NDV anti-
serum previou,sly prepared in rabbits was diluted seIially two-
fold in 0.25 ml with PBS,and to each cup 4 HA units contained 
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0.25 ml and 0.5 ml of 0.5% chicks RBC's were added and refrig 
era"ted. Controls were set for HA, antiserum and RBC·s. HI 
titers were determined on the basis of the highest dilution 
of antiserum completely inhibiting hemagglutination. 
Antiserum 
The infected allantoic fluids (stock) were prepared 
in eggs as previously described. Antibodies against NDV were 
prepared in rabbits. The NDV containing fluids were inocu-
lated intraperitoneally in 2 ml amounts every second day for 
a period of 14 days. In the third and fourth week the rabbits 
received 1 ml of the infected fluids intravenously. The rab-
bits were bled a week after receiving the final inocculation. 
This immune serum was used in indirect fluorescent antibody 
techniques. 
Staining procedures and use of fluorescent microscopy 
Some staining of HeLa cells was done with carmine-
fast green stain (Frigan and Bird, 1963). Acridine-orange 
(Harleco-C.I. No. 46005) staining of HeLa cells was done as 
reported by Pollard and Starr (1962). This was 0.1% solution 
in McIlvaine citrate-phosphate buffer pH 3.B. The buffer was 
prepared as recommended by McIlvaine (1928). 
Staining with acridine orange was done as follows: 
HeLa cells on the cover slips were fixed for 5 minutes in 
", 
", 
, 
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a glacial acetic acid-ethanol mixture. After fixation, cells 
were rinsed with the buffer and stained with 0.01% acridine 
orange fbr four minutes. They were again rinsed with the 
buffer and immediately mounted in the buffer on glass slides. 
Indirect fluorescent antibody techniques were done 
according to Tamm and Wheelock (1961). HeLa cells were grown 
as for acridine orange staining. Cover slips with HeLa cells 
were washed with PBS, fixed in acetone for 15 minutes and 
dryed. They were again washed in PBS for 15 minutes and a 
drop of undiluted immune rabbit anti-NDV serum (HI titers was 
1:640) placed on the cover slip and incubated for 30 minutes 
in a humidified chamber at 37 0 C. After this, the cells were 
washed for 30 minutes in PBS, a drop of anti-rabbit globulin 
serum prepared in horses and conjugated with fluorescein iso-
thiocyanate was .. added and again incubated· for 30 minutes. 
Finally the cover slips were thoroughly washed in PBS for 30 
minutes and mounted in 20% glycerol in PBS and examined. Con-
trols were prepared with normal rabbit sera and treated as 
above. Some of the cover slips with infected HeLa cells were 
treated with ribonuclease to determine the localization and 
the synthesis of viral ribonucleoprotein. Therefore, prior to 
staining with fluorescent antibody, infected cells were treate( 
with 0.04% solution of RNAse in McIlvaine pH 3.8 buffer for 
1 hour at 37°C, after which time they were stained and treated 
as described above. 
~ 
. 
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PhotograQh~ 
-
Pictures were taken with Kodak Pony IV type of 
camera. For acridine orange and fluore~cent antibody photo-
graphy, a 35 mm high speed Ektachrone type B film was used. 
Exposure times were between 2-3 minutes. Carmine-fast green 
preparations were photographed using Ektachrome X film.Light 
source for fluorescent microscopy was A.C. Fluorolume. A 
Spencer microscope equipped with a dark field condenser was 
used. The following filter combinations were used. 
Acridine orange 
Fluorescent AB 
Exciter 
Corning #5113 (2mm) 
S-BG #12 (3mm) 
Barrier 
Wratten #15 
Wratten #15 
-CHAPTER IV 
RESULTS 
Titrations of viral stocks 
Prior to any work, it was important to measure and 
establish the infectious viral titers and their stability. 
For this purpose both stocks were titrated 3 times, using 10 
tubes of fibroblasts for each dilution. The results in 
Tables I and Ilindicate individual infectivity for each titra-
tion and also the mean infective titers with standard devia-
tions. These determinations were done in the span of one 
month; as the work progressed, titrations of both stocks were 
done with little or no change in viral titers. 
Th~. mean TCID50 of NOV for chick embryo 
fibroblasts was 5.2 x 10-7 and for 
VSV 4.0 x 10-6 • 
DruQ tolerance assays in chicken embryo fibroblasts 
The results of these experiments are contained in 
Tables III and IV. It can be seen that the spectrum of toler-
ated concentrations ranges from 0.3~g I ml for puromycin to 
more than 500 ~g I ml for urethane. Drug tolerance was esti-
mated as described in chapter on "Material and Methods." 
These concentrations were the maximal tolerated by the cells, 
and used in assays as described below. 
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gyalitatiye assays of viral infectivities in the Qresence 
sU drugs 
The results of these experiments are shown in Tables 
III and IV. It can be seen that phenoxy derivatives of acetic 
acid were unable to prevent cytopathic effect (CPE) by either 
virus. Three indole derivatives of the lowest fatty acids as 
well as indole itself were also ineffective. Naphthoxyacetic 
acid, naphthaleneacetic acid, maleic acid hydrazide, gibberel-
lic acid and beta-2-furylacrylic a~ids belong to the same 
category in their inability to inhibit either virus. 8-azagu-
anine showed promise with both NDV and VSV. The other two 
purine derivatives, namely 8-chloroxanthine and 6-furfurylam-
inopurine did not inhibit CPE. A marked effect on CPE was 
seen with dl-5-fluorophenylalanine (FPA). Both viruses were 
inhibited by 30'~g of FPA I ml of medium, and in both cases 
CPE was as low as I (Tables III and IV). 
Of the three antitumor substances, puromycin showed 
some promise in the inhibition of NDV, mitomycin C lowered 
CPE due to VSV and carzinophilin was ineffective. 
Guanidine HCI showed inhibitory activity for the 
CPE caused by both viruses, although the related compounds of 
urea and urethane had no effect. 
As is evident (Tables III and IV), only 5 compounds 
were active in these tests, and these were 8-azaguanine, FPA, 
. PUromycin, mitomycin C, and guanidine Hel. 
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gyantitative assays of viral infectivities in the presence of 
selected drugs 
--
Drugs were selected for these experiments on the 
basis of their ability to partially inhibit viral CPE in pre-
viouS experiments. The procedure had to account for the time 
period through which the adsorbed virus was exposed to the 
action of drugs and the limitation of having available mono-
layers of fibroblasts in which the measurements of infectivity 
were done. One wanted to determine the extent of the viral 
synthesis in the cells exposed to selected drugs, and express 
this quantitatively as a function of time exposure to the 
drugs. In this manner one can obtain information on the in-
fluence of drugs on viral multiplication (Crowther and Melnick 
1961). 
Ten tubes with chick monolayers, were infected with 
4x 105 virus TCID50 • After adsorption, cells were washed 
and maintenance media containing the drugs added. 
Figure I shows that FPA significantly inhibited 
multiplication of NOV. Five hours after viral adsorption, 
there were 280 TCID50 found in control and none in the tubes 
with FPA. After 33 hours exposure to FPA the activity was 
2.5 x 105 TCIDSO and 3.4 x 10
6 TCID50 in contro~. This repre-
sents an infectivity loss of 92.7%. In other words the in-
fectivity in FPA treated cells represented only 7.3% infectiv-
ity of controls. In the same manner the infectivity of VSV 
~~~------------~ 
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control after 33 hours was 1.6 x 105 TCID50 and only 2.4 x 
104 TCID50 in the presence of FPA, a loss of 85% (Figure 5). 
Guanidine.HCl (Figures 2 and 6) was more inhibiting 
in early hours after viral adsorptions. The titers obtained 
later were comparable to controls. 
In the case of 8-azaguanine there is a slight in-
hibition of virus multiplication. NDV was somewhat more in-
hibited than VSV. VSV titers are very close to the titers of 
the control, and probably not significant (Figures 3 and 7) • 
. Puromycin (Figure 4) somewhat suppresses early NDV 
titers, which later on approach the titers of control. 
Figure 8 shows clearly that mitomycin C did not influence the 
synthesis of VSV in chicken embryo fibroblasts. 
As it can be seen from these experiments, the only 
significant inhibition of viral multiplications was caused 
by FPA. 
Ihe jnfluence of FPA on viruses 1n y1tro and measurements of 
their infect1yities whgn FPA addgd during different time in-
ieryals of latent per10d e Effect of FPA on free virus 
Results of these experiments are contained in Tables 
V and VI. Control titers in these experiments are similar to 
Viral titers in Tables I and II, which were obtained under 
completely normal conditions. Titers obtained in monolayers 
when FPA was added at different times during latent period are 
,.......-
, 
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significantly lower from control titers~ The significance of 
~his experiment will be discussed in chapter on "Discussion." 
lhe influence of FPA on the formation of NDV hemagalutinin in 
chick embryo fibroblasts 
-
In these experiments the mono layers of chick embryo 
fibroblasts were infected with usual doses of NOV. Five HA 
titrations were done in each case, reciprocal of the titers 
were averaged, and expressed in percentages of hemagglutina-
ting activity of controls. Average titers as well as percent 
of HA is.given in nearest whole numbers in Table VII. 
It can be seen from Table VII that the FPA inhibits 
hemagglutinin production of NOV. Ten pg of FPA did not have 
any effect. Twenty pg lowered HA production to only 86% of 
controls. In the presence of 30pg of FPA, HA production was 
only 18% of the normal controls. 
The influen_c~ of FPAon the survival of chicken embryos in-
fected with NOV and VSV 
The results of these experiments are tabulated in 
Tables VIII and IX. It can be easily seen that in the sur-
Vival experiments with NDV (Table VIII) there are, after 10 
days, 21 dead and6 survivors in controls, which received the 
Virus but no FPA. Experimental batch on the other hand shows 
13 deaths and 13 survivors after the same period of time. In 
the same manner (Table IX) VSV control shows 21 dead and 4 
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alive embryos whereas FPA treated batch has 17 deaths and 9 
survivors. 
The significance of .these results has been analysed 
statistically, using for this purposeX2 test (Batson, 1958) 
for small numbers. 
In the case of NDV. the obtained X2 for one degree 
of freedom was 4.19 and p<O.05. 
The X2 obtained from VSV experiments was 1.87~ 
giving a p>O.30. This would mean that FPA protected or pro-
longed the survival time of chicken embryos significantly ~n 
the presence of NDV but not when infected with VSV. 
The studies on the inhibitory mechanism of FPA 
The effe~t of high concentrations of FPA OD the synthesis of 
NDV in HeLa cells 
Results obtained can be seen in Jable X. Infectivi-
ty of control reached 2.1 x lo6TCID50. The extent of infec-
tivity in tubes.exposed to FPA inhibition for 8 hours, which 
Was then released by washings and phenylalanine, was 4.3 x 
lo4TCID50. Finally, the entire 24 hour exposure to FPA yield-
ed upon titration only 302 x lo2TCID50. 
The FPA inhibition was so thorough, that 24 hour FPA 
inhibited samples represent 0 0 015% infectivity of controls. 
Tubes.in which the FPA inhibition was released after 8 hours 
still reached only 2% of infectivity in controls. 
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The effect of FPA on RNA of normal and NDV-inf~cted HeLa cells 
-
From Table XI the following relationship is dis-
cernible. If 24 hour normal control is considered ~OO% then 
there was increased RNA synthesis in NDV infected cells during 
this period of time. The samples show approximately 11% more 
of PER. Cells exposed to FPA at time 0 show only 58.6%, a few 
percent lower than normal cells extracted at time O. Infected 
cells in the presence of FPA still put together some specific 
acid insoluble material, which on the basis of ribose accounts 
for 67.2% of the total that could be expected. Despite this, 
the PBR in this case is somewhat higher than PBR obtained from 
normal cells at 0 hour. Cells in which the FPA inhibition was 
released after 8 hours, resume RNA synthesis at normal rate. 
Morphological and histochemical studies 
Normal and infected HeLa cells were stained by Car-
mine-fast green stain (Frigan and Bird, 1963), to determine 
changes in microscopic appearance of infected cells. Cells 
infected wifu NDV (Figures 10-13) show formation of vacuoles 
and syncytia as compared to normal HeLa cells (Figure 9). 
Figure 13 shows complete destruction of monolayer of HeLa 
cells by NDV. Normal and cells infected with NDV were stained 
with acridine orange {Pollard and Starr, 1962} to study any 
change in content and distribution of nucleic acids. Figures 
15-18 show the changes from orange to deep red fluorescence, 
rr~ __________________________ ~~ 
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indicating an increase in content of RNA due to NDV. In the 
presence of FPA this shift in fluorescence was inhibited 
(Figures 19-21). In the infected cells the syncytia and 
vacuoles were also present. In the presence of FPA the in-
fected cells did not form syncytial masses or vacuoles, but 
the cells did show irregular "bumpiness" at the surface. Fig-
ure 14 shows normal HeLa cells at time zero, and Figure 22 
shows normal cells cultivated through the time period of ex-
periments. 
The HeLa cells were stained by indirect fluorescent 
antibody techniques (Tamm and Wheelock, 1961) to demonstrate 
the presence and location of specific viral material. Figures 
23 and 33 represent controls. Figure 23 represents normal 
cells stained with anti-NOV antibody and fluorescent tagged 
"" 
antibody, and Figure 33 shows infected cells stained with nor-
mal serum and fluorescent antibody." In both there was no 
fluorescence observed. Figures 24~ 26, 28 and 30 show develo~ 
ment of specific fluorescent material. Figures 25, 27 and 29 
demonstrate inhibition of this specific fluorescent material 
by FPA. Infected cells treated with RNAse and stained with 
fluorescent antibody techniques demonstrate that this fluores-
cent material is ribonucleoprotein (Figures31 and 32). 
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TABLE"I 
Titration of NDV Allantoic Stock in 
Chicken Embryo Fibroblasts 
Di1. lnf. Not inf. % inf. Neg. log.TCIDSO TCIDSciml 
10-4 10 0 100 
-6.23 S.8x107 
10-5 10 0 100 
10-6 6 4 63 
10-7 1 9 7 
10-8 0 10 0 
"10-4 10 0 100 -6020 6.3xl07 
10-5 9 1 94 
10-6 6 4 61 
10-7 2 8 13 
10-8 0 10 0 
10-4 10 0 100 
-6.44 3.6xl07 
10-5 10 100 
10-6 6 4 70 
10-7 3 7 21 
10-8 0 10 0 
-
S2 
= 2.58 
S = 1.60 
Mean TCID50 502 x 10
7 + 1.60 = 
r 
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TABLE II 
Titration of VSV Allantoic Stock in 
Chicken Embryo Fibroblasts 
Dil. Inf. Not inf. % inf. Negolog. TCID50 TCID501ml 
10-3 10 0 100 
-5022 600 x 106 
10-4 9 1 94 
10-5 6 4 61 
10-6 2 8 13 
10-7 0 10 0 
10-3 10 0 100 
-5040 3.9 x 106 
10-4 8 2 90 
10-5 6 4 64 
10-6 4 '. 6 29 
10-7 1 9 4 
10-3 10 0 100 
-5.66 201 x 106 
10-4 10 0 100 
10-5 7 3 80 
10-6 4 ,- 35 0 
10-7 1 9 5 
S2 
= 3.81 
S = 1.95 
Mean TOlD = 4.0 x 106 :t 1.95 
~. -~--------------------~----------------------------. 
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TABLE III 
Cytopathic Effect of l~'ewcastle Disease Virus 
in the Presence of Positive Drugs 
Tolerated Drug Solvent Conc.Jlg / ml 
Beta-naphthoxyacetic acid O-chlorophenoxyacetic acid 
2,4,5-trichlorophenoxy-
acetic acid 
Indole 
Indol.e-3-acetic acid 
Indole-3propionic acid 
Indole-3butyric acid 
Napththaleneacetic acid 1,2-benzanthracene . 8-azaguanine 
8-chloroxanthine 
6-furfurylamino~urine 
dl-~-fluorophenylalanine 
f ormyl-dl-phenyl alanine 
Chloracetyl-dl-phenyl-
alanine 
Mitomycin C 
Puromycin 
Carz1nophy1in 
Guanidine. Hel 
Urea 
Azaserine Quercetin 
Isatin-beta-thiosem1 Carbazone 
Adeno-PAP-#lO.87 
2 
1 
2 
2 
2 
2 
2 
2 
3 
3 
4 
4 
4 
4 
4-
4 
4 
4 
1 
4 
1 
1 
1 
2 
4 
1 
80 
50 
40 
250. 
220. 
200. 
200. 
80. 
250. 
5, 
10 
20. 
30 
60. 
50 
5 
0.3 
8 
125 
450 
80. 
120. 
100 
150. 
CPE 
Tubes 
4 3 4 4 
4 3 4- 4-
4 3 4 4 
4 3 4 4 
4 3 4 4 
4 3 4 4 
4 3 4 4 
4 3 3 4 
4 3 4 4 
3 2 3 3 
4 3 4 4 
4 3 4 4 
2 1 2 2 
4 3 3 4 
4 3 4 4 
4 3 3 4 
3 2 3 4 
4 2 4 4 
3 2 3 3 
4 3 4 4 
4 3 4 4 
4 3 4 4 
4 3 4 4 
4 3 4 4 
No activity whatsoever was recorded with the following compounds beta-2-furyl-acrylic acid, 100 ug; p-chlorophenoxyacetic acid, 
. 40 ug; 
2,4--dichlorophenoxyacetic acid, 40 ug; maleic acid hydrazide, 150 ug; 
gibberellic acid, 150 ug; urethane, 500 ug. Solvents: 1 = water; 2 = 95% ethanol; 3 = chloroform; 4 = 0.1% NaHC03 
TAB.LE IV 
Cytopathic Effect of Vesicular Stomatitis Virus 
in the ~resence of Positive Drugs 
Tolerated Drug ;::>olvent Conc. }J.g / ml 
2,4-dichlorophenoxy- 2 40 acetic acid 
2,4,5-trichlorophenoxy-
acetic acid 2 40 N~phthaleneacetic acid 3 80 8-azaguanine 4 5 8-chloroxanthine 4 10 6-furfurylaminopurine 4 20 dl-p-fluorophenylalanine 4 30 Formyl-dl-phenylalanine 4 60 
. Acetyl-d-phenylalanine 4 60 Chloracetyl-dl-phenyl- 4 
alanine 50 Mitomycin 0 4 5 Puromycin 1 003 
Carzinophylin 4 8 Guanidine. HOI 1 125 Quercetin 2 120 
Isatin-beta-thiosemi-
carbazone 4 100 
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OPE 
Tubes 
3 4 4 4 
3 4 4 4 
3 444 
2 3 3 3 
3 444 
3 444 
1 2 2 2 
'Z 444 .,I 
3 444 
3 444 
3 3 3 4 
3 3 4 4 
3 444 
3 3 3 4 
3 444 
"% 4 4 4 .,; 
No activity was recorded with the following compounds: beta-2-furyl-acrylic acid, 100 ug; beta-naphthoxyacetic acid,80; O-chlorophenoxyacetic acid, 50; p-chlorophenoxyacetic acid,40j Indole, 250 ug; indole-3-acetic acid, 220 ug; indole-3-propionic acid, 200 ug; indole-3-butyric acid, 200 ugj maleic acid hydra-. zide, 150 ug; gibberellic acid, 150 ug; 1, 2-benzanthracene , 250 ug; urea, 450 ug; urethane, 500 ug; azaserine, 80 ug; adeno-PAP #1087, 150 ug. 
Solvents: 1 = water, 2 = 95% ethanol, 3 = chloroform, 4 = 0.1% NaH003 • 
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TABLE V 
The Influence of FPA on NDV Titer When Added During 
Different Intervals of Latent Period. 
NDV Exposed to .bIPA* in Vitro 
for Six Hours 
0.01% LH - FPA Medium Hours 
After Adsorption 
o 
1 
2 
3 
control (no FPA) 
*JfPA cone. 30 pg/ml 
2.4 x 106 
108 x 106 
3.2 x 106 
4.1 x 106 
4.4 ;. 107 
r 
I 
-
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TABLE VI 
The Influence of FPA on VSV Titer When Added During 
Different Intervals of Latent Period. 
VSV Exposed to FPA* in Vitro 
for Six Hours 
0001% LH - FPA Medium Hours 
After Adsorption 
o 
1 
2 
3 
control (no FPA) 
TCID50 
1.8 x 105 
3.4 x 105 
3.6 x 105 
7.1 x 105 
3.2 x 106 
*FPA conc. 30 pg/ml 
... 
TABl.E VII 
The Influence of .lfPA on the Formation 
of NDV Hemagglutinin in Chick 
Embryo Fibroblasts 
pg FPA / m.l Medium 
o 
10 
20 
30 
HA Titer 
22 
22 
19 
4 
% HA 
100 
100 
86 
18 
46 
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TABLE VIII 
The Effect of FPA on the Mortality of Chicken 
Embryos Infected with NDV. Control Group 
Received 100 TCID50 of Virus/Egg. 
Experimental Group Received Virus 
NDV 
NDV 
FPA 
Total 
2 
X (c)l = 
in the Presence of 75 Pg of 
EPA/Egg. Both Groups 
Inoculated Allantoi-
cally and Experiment 
~L'erminated at Hatch-
ing Time. 
Embryos 
Alive Dead 
6 21 
13 13 
19 34 
4.19 p <:::. 
Total 
'C.7 
26 
53 
0.05 
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TABLE IX 
The Effect of FPA on the Mortality of Chicken 
Embryos Infected with VSV. Control Group 
Received 100 TCID50 of Virus/Egg. Experimental Group Received Virus 
in the Presence of 75 Pg of 
lJ'PA/Egg. Both Groups 
Inoculated Allantoi-
cally and Experiment 
Termin~ted at Hatch-
ing Time. 
Embryos 
Alive Dead Total 
VSV 4 21 25 
VSV 
FPA 9 17 26 
Total 13 38 51 
2 X (c)l = 1.87 P':> 0.30 
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'::'2-~:;;' Cells 
For 
C:-ntrol 
:"",0.0 
2.0 
0.015 
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TABLE XI 
Purine Bound Ribose (PB~)Estimations on RNA Extracted 
from HeLa* Cells UnQer Various Treatments. 
FPA Conc. 300 J1g / Ml of MEM 
Treatment }Jg PHR % Control at 
Normal cells 
- 0 hour 18.8 62.2 
Normal cells 
- 24 hours 30.2 100.0 
NDV infected cells - 24 hours 3305 110.9 
Cells - FEA - 24 hours 1707 5806 
Cells - NDV - FPA - 24 hours 20.3 6702 
Cells 
- NDV - FPA - 8 hours 26.0 8600 
* 3 x 106 cells per tube 
24 h 
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CHAPTER V 
. DISCUSSION 
Of the three gen~ral methods available for the study 
of viral chemotherapy,. the tissue cuI ture method and the em~ 
bryonated egg method were chosen. The tissue culture method 
is preferable in spite of some criticism that it does not in-
dicate whether an antiviral drug will be active in an infected 
animal. This same criticism has been raised in the case of 
in vitro antibacterial antibiotics tests. It is understand-
able that an in vitro test (Hermann, 1962) can not reflect all 
the in vivo factors acting on adsorption, excretion, toxicity 
and detoxification of the test drug. All the drugs, therefore 
which exhibit ~tgh activity in vitro and low or no activity in 
vivo, should be returned to the laboratory for the modifica-
tion of the molecule and further investigation. 
The final and crucial tests on the selected anti-
viral agents in vitro, should be done in laboratory animals. 
Tissue culture methods used in this work were of 
two types. The method of Herrmann et al., (1960) employs 
agar-diffusion for the detection and bioassay of antiviral 
drugs. The method was tried at the start of this work and 
was modified several times. The results obtained were incon-
sistent and therefore it had to be abandoned. Parallel with 
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this, a liquid type of tissue culture method was used (Right-
sell et al., 1958) which was modified according to our needs. 
It consisted of preparation of monolayers (Dulbecco, 1952) of 
chick embryo fibroblasts in which the various drugs in solutio 
were then assayed for aritiviral activity. This method gave 
good and reproducible results. In order to use a liquid type 
of tissue cultur~ in chemotherapeutic work, two important re-
quirements had to be considered here. The proper solvents 
must be selected for the drugs to be tested so that they can 
be removed from the media once the drugs are dissolved. 
The second problem was the variation of the pH of 
the media due to the presence of the test drug. Mammalian and 
avian cells exhibit normal activities of metabolism and growth 
in a narrow range of hydrogen ion concentration. The physio-
'. 
logical pH for these' cells is between 7.2 - 7.6 and it is im-
portant that the starting cultures of such cells be within 
this pH range. The pH of the medium containing the variety of 
the drugs was adjusted and buffered for this range. 
Assays of drug tolerance of chick embryo fibroblasts 
were done prior to work with viruses. Viral synthesis inside 
a susceptible host cell is intimately associated with cellular 
enzymatic processes. It is, therefore, necessary to deal with 
the highest possible concentrations of the drugs tolerated by 
the cells in order to expect chemotherapeutic action based on 
selective toxicity. The therapeutic concentrations in many 
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instances approach toxic levels, and it is in such situations 
very difficult to dissociate therapeutic effect of a drug from 
its toxicity. 
Toxic concentrations induce changes in the cells 
which are difficult Or impossible to distinguish from the 
effects due to the virus. 
The effects of viral multiplication in tissue cul-
tures may be detected in a number of ways. Degenerative 
changes in the cells or pH changes take place as the result of 
decreased metabolism. One can also harvest viral fluids and 
inoculate serial dilutions into animals or developing chicken 
embryos and calculate the 50% infective, lethal or paralytic 
doses. One can also estimate hemagglutinin (HA) or comple-
ment fixing (CF) titers from fluids. In this work the cri-
teria of viral presence was cytopathic effect (CPE), hemag-
glutinin production and histochemical changes. Huang (1942), 
and others recognized, that the mUltiplication of viruses or 
their presence in tissue cultures brings about degenerative 
ch?nges, which provide adequate proof of their presence. These 
changes are generally described as cytopathic effect. Dif-
ferent viruses affect different cells in a variety of ways. 
The cytopathic effect comprises all the changes in virus in-
fected cells which make them appear granular, rounded up, ac-
cumulated in irregular masses without a clear distinction as 
to individual cells, and finally degeneration and complete 
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disintegration. These changes had to be specifically induced 
by viruses in order to decide any therapeutic potential of 
drugs. 
Qualitative assays of infectivity in the presence 
of the drugs were performed to select the drugs with potential 
antiviral activities. Even the partial inhibition of CPE in 
such tests is adequate reason to consider any inhibitive drug 
as a potential therapeutic. From Tables III and IV it can be 
seen that only five drugs passed the criteria as formulated 
in the chapter on "Materials and Methods.". These drugs were 
mitomycin C, guanidine Hel, 5-fluorophenylalanine, 8-azaguan-
ine and puromycin. 
But the lowering of CPE per se might not always mean 
reduction in infectious titer or suppression of viral multi-
plication. Groupe, et alo, (1952, 1954) have shown this in 
vivo with xerosine. 
This possibility was investigated in vitro with 
drugs in qualitative assays by measuring the infectivities 
after different time intervals of exposure to the drugs. The 
lowering of the CPE in such situations with no inhibition of 
viral multiplication could still be considered therapeutically 
effective. Whatever the meaning of inhibited CPE in such 
situations might be, when projected in vivo it can mean two 
things: Either disappearance of the symptoms or the drug is 
provoking tissue reactions which are manifested by a decrease 
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in cellular destruction. In some human diseases, for example 
influenza, the disappearance of the symptoms in spite of ex-
tensive viral multiplication could be regarded as beneficial, 
(Herrmann, 1962). 
From the results (Figures 1-8) of quantitative 
assays of viral infectivities in the presence of drugs which 
previously inhibited CPE, only FPA inhibited the multiplica-
tion 'of viruses significantly. 
The inability of mitomycin C to inhibit multiplica-
tion of VSV (Figure 8) can be explained on the basis of obser-
vations of several groups (Reich and Granklin, 1961; Shatkin 
et al., 1962; Ben Porat, et al., 1961). Mitomycin C apparent-
ly acts only on DNA of the cell and the virus, and since VSV 
is an RNA containing virus (Hossein and Cooper, 1963), mitomy-
cin C does not affect its multiplication. Puromycin did not 
suppress the multiplication of NDV (Figure 4) at concentration 
tolerated by cells. Higher concentrations of puromycin 
(5 ug / ml) Levintow, et al., (1962) inhibit poliomyelitis 
virus in HeLa cells, but this concentration is extremely toxic 
for the cells. 
Guanidine.Hel (Figures 2 and 6) influences the mul-
tiplication of NDV and VSV only early after adsorption. Later, 
the final titers of both viruses approached the titers of con-
trols. Melnick, et al., (1961) reported that low doses of 
guanidine. HCl, at least with enteroviruses, select viral 
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particles with varying degrees of resistance to the drug. This 
mechanism might explain the early lower titers in our case. 
Guanidine.HCl inactivated a certain proportion of initial in-
fective dose of each virus giving less infectivity in fhe be-
ginning, which picked up later and reached the control titers. 
8-azaguanine was ineffective with VSV. The titers 
(Figure 7) were very close to the titers of control. In the 
case of NDV (Figure 3) 8-azaguanine shows small but definite 
inhibition. Despite this the viral titers are wthin one 
standard deviation of controls. It would be interesting to 
work with some other guanine derivatives. 
The only drug showing significant inhibition of mul-
tiplication of both viruses was FPA. FPA (Figure 1) lowers 
the final NDV t.iters to approximately 7% of control. At 5 
hours after adsorption, titer of the control was on the aver-
2 
age 2.8 x 10 TCID50 whereas titer of FPA inhibited test was 
below 102 TCID50 and therefore not measurable using tenfold 
dilutions. Similar results were obtained with VSV (Figure 5)0 
The differences between both viruses is in their infectivity 
for chicken embryo fibroblasts. Titration of NDV stocks in 
chick fibroblasts always gave higher titers than the stocks 
of VSV. The reason for this probably lies in the nature of 
host-virus system. Chicken cells provide a natural host for 
NDV which is not the case with VSV, which is a natur~l patho-
gen of horses and cattle. 
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The lower titers (Franklin, 1958) of both viruses in 
these tests as compared with the titers achieved in direct 
titrations of allantoic stocks are without doubt due to some 
viral inactivation during freezing and thawing of the cells. 
Despite this fact, the relative inhibition of viral multipli-
cation in the presence of' the drug is still evident from these 
experiments. 
Rubin et al., (1957) showed that 95% of cell asso-
ciated NOV can be neutralized by immune serum. Since it is 
known that the antibody molecule does not enter the living 
cell, thisneutralizable but cell associated virus (CAV) must 
be somehow exposed to the action of antibody. NOV is asserrbled 
in the cytoplasmic membrane and remains, after maturation, 
connected with~e' outer cellular surfaces for approximately 
one hour, after which it is finally released into the medium. 
Because of this, there existed a possibility that FPA might 
be acting extracellularly, namely either on the virus still 
associated with cell or on free virus in the medium. In order 
to be sure that FPA does not act as a virucidal agent on the 
viruses used in this work, experiments were performed to test 
this possibility. FPA had no effect on the free virus as seen 
from control titers (Tables V and VI). Nor did FPA exhibit 
any detrimental effect during the adsorption period. 
Ellis and Delbruck (1939) with bacterial viruses and 
Dulbecco and Vogt (1954) with animal viruses demonstrated that 
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after penetration of viral nucleic acid into a susceptible 
cell, a period follows during which the infectivity cannot-
be measured or recovered, and any remaining measurable infec-
tivity is due to free and unadsorbed virus. Also during this 
period of time no virus specific material of any kind can be 
detected within such cells. After this period, which in dif-
ferent systems may take a few minutes, several hours or even 
days, viral specific materials start to appear, but measurable 
infectivity, if any, is still due to residual free virus. This 
time period is called the eclipse phase, and together with the 
maturation phase, (time interval in which first viral material 
starts to appear and up to the time when the first increase in 
infectivity is detected) comprises the "latent period" of viral 
development. 
The latent period of NDV in chick embryo fibroblasts 
is approximately 3 hours (Levine and Sagik, 1956), of which 2 
hours (Tamm and Wheelock, 1961) are taken by eclipse. The VSV 
latent period in the same host is between 2.5-3 hours, of 
which 1.5-2 hours belongs to the eclipse (Franklin, 1958). An 
infected cell culture (low multiplicities) exhibits contin-
uously all phases of viral development; new cells are infected 
during release of finished virus products; in some of the 
cells virus is eclipsed, in the others in the process of matu~ 
ation and so on. (Tables V and VI). The suppression of viral 
infective titers was evident when FPA was present during 
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different time intervals of the latent period as well as 
throughout the extended periods, indicating the intracellu-
lar action of FPA (Tables V and VI). 
When FPA is present in a glycerol-salt medium dur-
ing the adaptation of Ee coli to lactose fermentation, the 
growth rate of the organism becomes linear rather than ex-
ponential (Munier and Cohen, 1959). Such a possibility is 
discernible from the experiments with NDV hemagglutinin 
(Table VII). There is, of course, no analogy between EeColi 
and its galactosidase on one side a~d the synthesis of viral 
hemagglutinin by mammalian or avian cellon the other. The 
similarity is the ability of both to synthesize enzyme pro-
teins. If FPA renders a bacterial enzyme nonf~nctional by 
virtue of its incorporation into the enzyme molecule, there i 
a good possibility that a similar sequence of events will oc-
cur in virus infected cell in the presence of FPA.Zimmerman 
and Schafer (1960) showed in the case of fowl pl~gue virus 
that the presence of FPA during the eclipse phase inhibits th 
synthesis of viral protein. Later addition of FPA allows the 
formation of S antigen but not of viral hemagglutinin. The S 
antigen of myxoviruses is believed to be a nucleoprotein, 
which forms before the capsid protein containing HA activity. 
In our experience, 30 ug of FPA lowered the HA ac-
tivity of virus to about 18% of the titer of control. Does 
FPA cause synthesis of less infectious virus or of nO'1furcticoal 
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HA? If there is less virus formed there is also less hemag-
glutinin formed. On the other hand the viral nucleic aeid 
could be infective but HA is not functional. 
In order to determine the effect of FPA on viruses 
under more realistic conditions, namely iri a living host that 
is easily infected and killed by the virus we used embryonated 
chicken eggs. Embryos are suitable for this purpose~ although 
there are some disadvantages involved. The factors which had 
to be considered were as follows: toxicity of FPA, dose of the 
virus which had to be large enough to infect and kill, but 
also small enough so that it could be acted upon by relative-
ly .nontoxic doses of FPA. 
In the case of NDV, 75jUg of FPA protected or pro-
longed the time of survival of infected embryos significantly. 
This conclusion is based on the outcome of statistical analy-
sis of the results. However, embryos were not protected 
against VSV as revealed from chi square tests. This differ-
ence could be due to the nature of the virus and the response 
of embryo host. VSV, although "adapted," is not a natural 
pathogen for chickens. If epidemiological theory is correct, 
such a relationship is much harder for host than an infection 
with natural pathogen. 
The e~periments which were undertaken to study the 
mechanism of FPA inhibition were of three kinds. 
Again the infectivity of virus synthesised during 
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exposure to a large concentration of FPA had to be measured 
and compared to noninhibited controls as well as to the in-
fectivity obtained from FPA inhibited cultures in which the 
inhibition was later released by removal of FPA containing 
medium and introducing medium rich in phenylalanine (PA). 
Secondly, an important component of the cells had to be ob-
tained and measured under variety of treatments, a component 
which could be, during internal virus development, shared 
with the virus or at least have a biological function similar 
to one of the viral components~ And thirdly, the individual 
results obtained in the.rJISttwo steps as well as the conclusions 
extracted should be then analysed in connection with the re-
sults obtained from histochemical experiments. In order to 
insure as much··uniformity as possible, a homogenous cell cul-
ture had to be used in these experiments. HeLa cells are 
preferable over primary chicken fibroblasts. A homogeneous 
cell line was preferred in histochemical studies because of 
morphological considerations as well as for analytical reasons 
inc biochemi cal experiments. 
Addition of FPA during early eclipse period and its 
presence during a24hour period completely suppresses the form-
ation of infectious viral particles (Table X). Any infectiv-
ity recorded was probably due to some residual unadsorbed 
virus. The hemagglutinin activity was zero, indicating that 
there was no synthesis of protein or at least functional 
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hemagglutinin. Infected cells exposed to FPA for 8 hours and 
in which the inhibition was then reversed, showed a signifi-
cant in~rease in infectivity over 24 hours inhibited samples. 
But the HA activity of this .sample was the same as in the 
sample inhibited for 24 hours. There was actually a 134 fold 
increase in the infectivity over the 24 hour sample, whereas 
HA activity remained the same. Only in the control sample 
which was not exposed to FPA, HA activity was recorded at 
4 HA units. The possibility that FPA inhibits hemagglutinat-
ing activity in vitro was tested with the virus from controls. 
This was not the case, since dilutions were made in medium 
containing FPA, and the hemagglutinating activity remained 
steady at ~ HA units. From these experiments we conclude that 
FPA inhibits ~?th infectivity and HA production acting intra-
cellularly. Reversal of FPA inhibition results in the in-
crease of infectious titer, .but there is still not enough 
virus to give ,concentrations of enzyme necessary to agglu-
tinate red blood cells o 
Since NDV is an RNA containing virus and since vira 
infection implies the synthesis of viral &~A, we wanted to 
study the influence of FPA on the RNA synthesis of normal 
cells, and virus infected cells in order to obtain further 
information on the mechanism of FPA inhibition. 
This was done by the determination of ribose con-
tent in RNA extracted from HeLa cells which underwent diff~nt 
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treatments. If the purine-bound ribose from tubes of 24 
hours growth of normal HeLa cells represents 100% (Table XI), 
then there is a net increase of approximately 11% of ribose 
in-the cells infected with NOV despite their progressive des-
truction. This indicates either viral RNA synthesis, or at 
least increase in acid insoluble material whLch is well on its 
way to incorporation either in cellular or viral RNA. On the 
dher hand, purine bound ribose from infected cells in the 
presence of FPA was only 67.2% of ribose re~orded in normal 
24 hour controls. Compared with normal cells which were cul-
tivated through the same time period in the presence of FPA, 
these infected FPA inhibited cells still show some increase 
(8.6%) over the PBR value obtained in noninfected FPA inhibi-
ted control. This would mean complete inhibition of RNA syn-
thesis in normal cells treated with FPA, but some synthesis 
in-infected FPA treated cells. These PBR values are compared 
to normal controls at 0 time, which in the terms of 24 hours 
normal control represents only 62.2% of the net amount. 
Finally the infected and 8 hour FPA treated cells in which 
, 
the inhibition was counteracted by washings and phenylalanine 
gave a PBR value of 26.0 ug which is much higher than the 
value obtained with infected - FPA treated cells for 24 hours, 
but still smaller (86%) than value obtained from infected and 
untreated cells. This indicates that the RNA synthesis in 
this case continued after re~se of FPA inhibition. 
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Histochemical studies done on HeLa cells in con-
nection w~th above work corroborate these findings, and in 
some instances expand these results. Acridine orange studies 
clearly reveal the changes in the infected cells that are due 
to the viral infection. The gradual accumulation of viral 
RNA (Figures 14-18) in the infected cells is shown by the 
shift in color (Armstrong, 1956; Schummelfelder, et al., 1957) 
from reddish-orange to dark flame red. Infected, but FPA 
treated cells do not undergo this shift, or at least this is 
. not very pronounced (Figures 19-21). This agrees with the 
experiments on purine bound ribose obtained from infected-FPA 
treated cells. In spite of this fact, there appears, on the 
basis of PBR experiments (Table XI) the possibility of some 
viral RNA synth,esis in such cells. Acridine orange is not 
sensitive enough to detect this change. Fluorescent antibody 
techniques (Figures 23-30) reveal the formation of vi~al 
specific material in the cells despite the presence of FPA, 
which from previous experiments, definitely inhibits the pro-
duction of infective viral particles and hemagglutinin. Viral 
material is synthesised in such cells although to a lesser ex-
tent. In the FPA inhibited cells exhibiting specific viral 
fluorescence, virus material could be nucleoprotein or S Anti-
gen. Treatment of such cells with ribonuclease (RNAse) for 
one hour at 37 C removes this fluorescent material (Figures 
31 and 32)0 This material could not be viral nucleic acid 
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alone, because nucleic acids are not antigenic, and therefore, 
cannot be responsible for the induction of antibody forma-
tion. 
It is therefore possible that ribonucleic acid in 
this case is hapten t which is broken down to oligonucleotides 
and smaller units through the action of RNAse. Immunologic 
specificity is lost, and as a consequence, fluorescence also. 
The question that arises here is as follows: if high 
concentrations of FPA inhibit RNA synthesis, a conclusion 
drawn from previous experiments, how is it possible that viral 
RNA or viral ribonucleoprotein appears in such cells?t It 
seems that the assumption of Scholtissek and Root (1961), de-
rived from work on fowl plague virus t is pertinent in the case 
of NDV t namely.thata protein (polymerase), once formed in the 
early eclipse phase, directs the synthesis of some viral RNA 
or ribonucleoprotein. This might go on even during the time 
tha t FPA inhibits the forma tion of viral hema gglutinin and 
viral maturation. In such case, viral protein and nucleo-
prptein formed contains instead of phenylalanine the analog 
FPA. This material is immunologically active as shown with 
fluorescent antibody techniques, but inactive concerning its 
neuraminidase activity as well as its infectivity. 
SUMMARY 
Chemotherapeutic experiments involving 30 different 
drugs and two animal viruses yielded 2 drugs which have the 
ability to suppress the infectivity of Newcastle disease vi-
rus and vesicular stomatitis virus in tissue cultures. 
Of the two drugs, 5-fluorophenylalanine, an analog 
of amino acid phenylalanine, exhibited significant inhibition 
of infectivity of vesicular stomatitis virus and Newcastle 
disease virus as well as the inhibition of the formation of 
Newcastle disease virus hemagglutinin. 
The other selected drug, 8-azaguanine, an analog of 
guanine, had more effect on the infectivity of Newcastle dis-
ease virus, although not as significantly as 5-fluoropheny-
lalanine. 
In the experiments with fertilized chicken eggs, it 
has been shown that 5-fluorophenylalanine definitely prolongs 
the survival time of chicken embryos infected with Newcastle 
disease virus, which on the other hand cannot be claimed in 
the case of embryos infected with vesicular stomatitis virusol 
The studies on the mechanism of action of 5-fluoro-
.phenylalanine were done in HeLa cells and only with Newcastle. 
disease virus. For this purpose 10 times higher concentra- 1 
tions of 5-fluorophenylalanine (300~g Iml) were used than i 
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previous experiments, since the criterion of selectivity was 
not important in these studies. 
The biochemical studies revealed that 5-fluorophen-
yla.lanine inhibits general cellular RNA synthesis which would 
also mean inhibition of protein synthesis, which then reflects 
itself in the suppression of viral infective titers as well 
as in the production of enzyme neuraminidase responsible for 
hemagglutination. 
Upon release of 5-fluorophenylalanine inhibition, 
~y washing the cells and introducing into mediuffi normal amino 
.cid phenylalanine, the inhibition of viral infectivity stops, 
i.e., more infective virus is formed. From these experiments 
it is concluded that 5-fluorophenylalanine inhibits not only 
~he RNA and protein synthesis, but also the maturation of 
'. 
ully infectious viral particles. 
Histochemical studies, using acridine orange and 
~luorescent antibody techniques, confirm the above findings. 
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ABSTRACT 
Chemotherapeutic Experiments With Ribonucleic 
ACid Containing Animal Viruses. 
The purpose of this work was to select drug(s) 
which exhibit selective toxicity for 2 RNA con-
taining animal viruses, Newcastle disease virus 
(NDV} and vesicular stomatitis virus (VSV) when 
grown in primary cultures of chicken embryo 
fibroblasts,· and using biological, biochemical 
and histochemical techniques, to study the 
mechanism of action. 
Introduction: .. Chemotherapy of viral diseases is a difficult 
undertaking. The problem is not so much due 
to the unavailability of drugs, their solubili-
ties and active or passive transport into virus 
infected cells as it is due to the intricate 
relationship of the host-parasite system itself, 
Upon infection of a cell, viral nucleic acid, 
which is the carrier of genetic code for the 
synthesis of its own protein and nucleic acid 
subunits, reorients the aspect of cellular 
metabolism in the direction which provides all 
necessary enzymes, building blocks and energy 
for the formation of new viral material. The 
formation of viral subunits and theirsubse-
quent assembly into mature and fully infect-
ious virus is integrated with remaining cellu-
lar processes, so that it is difficult to 
achieve, by use of drugs, a significant toxic-
ity for the virus without disturbing normal 
cellular metabolism. Usually, a certain drug 
concentration which is toxic for virus or in-
hibitive for certain anabolic function{s) lead-
ing to the formation of virus is simultaneous-
ly toxic for other cellular processes. It is 
the intimate parasitic relationship at the en-
zymatic and molecular level in viral diseases 
which makes it difficult to efficiently sepa-
rate the antiviral action of drugs from their 
general toxicity for the infected hosts. 
In spite of this, certain drugs show selective 
toxicity for certain viruses, although almost 
entirely in vitro. Most of these studies on 
the chemotherapy of viral diseases had not as 
yet contributed to any significant practical 
use, although they were responsible for many 
interesting findings of the parasitism at the 
cellular and subcellular levels which I ~ 
Results: 
contributed to the general knowledge of virus-
cell relationship. 
It was logical, therefore, to assay or estimate 
in the beginning experiments the highest toler-
ated doses of various drugs in the cellular 
system in which most subsequent studies were to 
be performed. Only at such concentrations can 
one reasonably expect to achieve selective ac-
tion. For this purpose, chicken embryo fibro-
blasts were used and the assays were done using 
30 drugs in liquid tissue culture systems. Af-
ter ascertaining the highest tolerated doses of 
the drugs by chick embryo cells, the next step 
was to measure; qualitatively, the ability of 
these drug concentrations to suppress viral cy-
topathic effect (CPE) in chick cells. In both 
instances, 1000 TCID50 of virus were used to 
infect cell monolayers, which were then incu-
bated in the presence of medium containing the 
drugs, and observed for 3 to 5 days for the 
development of CPE, which was then scored as 
0, 1, 2, 3 and 4 when compared to controls. ThE ~ 
drugs showing inhibition of CPE under these con-
ditions were used in quantitative assays, to 
estimate specific loss of infectivity expressed 
in TCID50 when compared to controls, as well as 
to analyze the significance of this inhibition. 
On the basis of CPE inhibition in qualitative 
tests, 5 drugs were selected for quantitative 
studies. The drugs were 5-fluorophenylalanine, 
8-azaguanine, guanidine.Hel, mitomycin, and 
puromycin. 
Quantitative assays were performed by infecting 
5 chicken embryo monolayers with 4 x 10 TCID50 
of virus, and after adsorption, media were added 
containing the above drugs in highest tolerated 
concentrations. At 5, 10, 23, 28 and 33 hours 
after viral adsorption, the infected monolayers 
were frozen and thawed twice, cell debris sedi-
mented by centrifugation, and supernatants ti-
trated in chick cells grown in normal medium; 
titrations were done using Reed and Muench 
method. From the results of these studies it 
could be seen that 5-fluorophenylalanine (FPA) t 
significantly inhibits infectivity of both vir-
uses in chicken fibroblasts. NDV infected 
cells treated for 33 hours with 30 ug of FPA/ml 
of medium showed only 7.3% infectivity of con-
trols, whereas in the case of VSV the FPA 
treated cells showed 15% infectivity recorded 
in controls. 
Of the rest of the drugs only 8-azaguanine 
showed some inhibition of NDV, which on the 
basis of statistical approach was notsignifi-
cant. 
The addition of FPA containing medium to chick 
embryo monolayers during different times of 
latent periods of both viruses significantly 
lowered both infective titers, confirming above 
findings, whereas exposure of viruses in vitro 
to FPA did not have any effect on final titers 
in chick cells. 
It has been shown in the case of NDV that FPA 
significantly lowers its hemagglutinin titer. 
In the presence of 30 ug of FPA the NDV hemag-
glutinin activity was recorded and represented 
only 18% of HA activity of controls. Since FPA 
suppresses viral infectivities and in the case 
of NDV also the hemagglutinating activity, it 
is reasonable to assume that this is due to FPA 
incorporation into viral subunits rendering 
them nonfunctional. The experiments with FPA 
in embryonated eggs showed on the basis of sta-
tistical analysis that 75 ug of FPA significant-
ly prolongs the survival time of embryos in the 
case of NDV infections. VSV infected embryos 
on the other hand did not respond significantly 
to the treatment with FPA, and the reason for 
this could be sought in the epidemiological hy-
potheses. 
The studies on the actual mechanism of FPA in-
hibition were performed with only NDV. For 
this purpose homogeneous cell cultures (HeLa) 
were used in order to obtain more uniform re-
sults. It is shown that 300 ug of FPA per ml 
of Eagles MEM maintenance medium completely in-
hibits the formation of infectious NDV; this 
inhibition could be released as shown in the 
experiment with 8 hours FPA inhibited and NDV 
infected cultures. After thorough washing of 
such cultures with PBS and addition of MEM rich 
in phenylalanine synthesis of fully infectious 
virus takes place as revealed by increased 
viral titers. It has been further shown in the 
purine bound ribose experiments that FPA gener-
ally inhibits cellular RNA synthesis and that 
in spite of this fact some RNA is synthesized 
in virus infected cells. That this RNA could be 
of viral origin has been shown using histochem-
ical techniques, especially fluorescent anti-
body procedures. On the basis of these experi-
ments the following conclusions can be drawn: 
FPA inhibits yiral infectivity and hemaggluti-
nin, and general cellular RNA synthesis. Spe-
cific fluorescent material observed in the in-
fected and EPA treated cells is viral nucleo-
protein which is nonfunctional due to the pres-
ence of FPA moieties. Relea~e of FPA inhibitior 
results in the synthesis of normal virus, mean-
ing that FPA might inhibit also viral matura-
tion. 
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